Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.460 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,027
Open 1.460
Bid (Size) 1.290 (100)
Ask (Size) 1.460 (600)
Prev. Close 1.460
Today's Range 1.460 - 1.460
52wk Range 1.390 - 8.270
Shares Outstanding 9,377,034
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-69.6%
-69.6%
1 Month
-32.1%
-32.1%
3 Month
-35.1%
-35.1%
6 Month
-52.1%
-52.1%
1 Year
-65.6%
-65.6%

More News

Read More
News headline image
Life Science Virtual Investor Forum Agenda Announced for September 18th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
Via Chartmill
News headline image
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data ↗
Via Benzinga
News headline image
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
News headline image
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Via Newsfile
Topics Regulatory Compliance
News headline image
Here are the top movers in Tuesday's session. ↗
Via Chartmill
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Positive Preclinical Results for INM-901 in Alzheimer’s Neuroinflammation Model
Via Investor Brand Network
News headline image
Curious about the most active stocks on Tuesday? ↗
Via Chartmill
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Why InMed's Alzheimer's Drug Candidate Is Fueling Sudden Stock Surge ↗
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study
Via Newsfile
News headline image
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
Dow Dips Over 300 Points; Campbell's Posts Upbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Nano-Cap InMed Ignites Retail Frenzy As Stock Soars After Alzheimer's Drug Trial Shows Promise ↗
Via Stocktwits
News headline image
Crude Oil Down 2%; D.R. Horton Earnings Top Views ↗
Via Benzinga
News headline image
Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing ↗
Via Benzinga
News headline image
Dow Jumps 200 Points; 3M Posts Upbeat Q4 Results ↗
Via Benzinga
Topics Stocks
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Fiscal 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Intellectual Property

Frequently Asked Questions

Is InMed Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, InMed Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does InMed Pharmaceuticals Inc. - Common Shares trade on?
InMed Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for InMed Pharmaceuticals Inc. - Common Shares?
The ticker symbol for InMed Pharmaceuticals Inc. - Common Shares is INM on the Nasdaq Stock Market
What is the current price of InMed Pharmaceuticals Inc. - Common Shares?
The current price of InMed Pharmaceuticals Inc. - Common Shares is 1.460
When was InMed Pharmaceuticals Inc. - Common Shares last traded?
The last trade of InMed Pharmaceuticals Inc. - Common Shares was at 11/18/25 04:00 PM ET
What is the market capitalization of InMed Pharmaceuticals Inc. - Common Shares?
The market capitalization of InMed Pharmaceuticals Inc. - Common Shares is 13.69M
How many shares of InMed Pharmaceuticals Inc. - Common Shares are outstanding?
InMed Pharmaceuticals Inc. - Common Shares has 14M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.